In the news section: Marinomed, VIG, stock market outlook, SBO, UBM, Verbund (Christine Petzwinkler)


Marinomed news: The University of Swansea Medical School, UK has one clinical examination with an iota / kappa carrageenan nasal spray for Covid-19 prophylaxis planned for health workers (ICE-Covid). The study will recruit 480 doctors and nurses to care for Covid-19 patients. The aim of the study is to examine how effective Carragelose®-based nasal and throat sprays can reduce the frequency, severity and duration of Covid-19 infections. Further endpoints are the frequency of respiratory infections with other viruses, the user-friendliness of the spray in prevention and the effect on quality-adjusted years of life. The clinical trial is supported by Marinomed, the rights holder of Carragelose, and its UK distributor Boots. Carragelose nasal spray is sold in the UK under the brand name Boots Dual Defense.
Marinomed Biotech (

Current indication: 117,00 /120,00, -0,42%

The Vienna Insurance Group buys the insurance business in Hungary, Poland, Romania and Turkey from Aegon NV and thus takes over the companies in the non-life and life sectors as well as pension funds, asset management and service companies of Aegon in these countries. The The purchase price is 830 million eurosVIG announced that the closing is expected in the second half of 2021. The premium volume of the insurance companies in the four countries was the equivalent of around EUR 600 million in 2019, with a net result of around EUR 50 million. From today’s perspective, VIG assumes that the regulatory solvency ratio at closing will be within the communicated comfort zone of 170 to 230%.

Current indication: 20,00 /20,30, 2,60%

Outlook: The year 2021 will be a year of capital market opportunitiesJens Wilhelm, who is responsible for portfolio management and real estate on the Union Investment Board of Management, expects this. He sees the outlook shaped by negative real returns, an expansive monetary and fiscal policy and progress in combating pandemics. Wilhelm believes that stocks are particularly promising. “Profits will be price drivers in 2021. We expect global corporate profits to grow by up to 30 percent year-on-year,” he says. At the same time, the low or negative real returns keep valuations at an elevated level. “For stocks, that’s almost the best of all worlds“, says the capital market strategist. For the year as a whole he believes that the asset class will generate a return of up to 10 percent.” The economic recovery will help cyclicals as well as value stocks over the course of the year Stock selection: “Corona is a trend booster and leads to an increased differentiation between winners and losers.”

The analysts at Oddo BHF confirm that Buy recommendation for SBO and increase the target price from 39.0 to 43.0 euros. Kepler Cheuvreux confirmed for SBO das “Reduce” -Rating, but raises the target price from EUR 21.0 to EUR 26.0. MM Warburg remains UBM on “Buy” and increases the target price from EUR 47.0 to EUR 48.5. Kepler Cheuvreux confirmed Association with “Buy” and increases the target price from 60.0 to 75.0 euros.

Current indication: 27,95 /28,15, -1,41%

Current indication: 34,80 /35,40, -0,28%
Composite (

Current indication: 59,50 /59,75, 1,06%

(The input from Christine Petzwinkler for the of November 30th)

Photo credit

mind the gabb

Stocks on the radar:Semperit, FACC, DO&CO, Warimpex, Agrana, Telekom Austria, Austrian post, Erste Group, AT&S, Athos real estate, Addiko Bank, Andritz, Wienerberger, Strabag, Rosenbauer, OMV, AMS, Cleen Energy, startup300, Composite, SW environmental technology, Rather S, Varta AG, HelloFresh, EVN.

Random Partner

The technology group S&T AG has around 6,300 employees and branches in more than 30 countries worldwide. The company, which is listed in the TecDAX® and SDAX® on the German stock exchange, is one of the leading providers of IoT (Internet of Things) technologies. In these areas, S&T concentrates on the development of secure and networked solutions through a combined portfolio of hardware, middleware and services. In-house technologies in the areas of smart factories, train radio systems, medical technology, communication solutions and smart energy as well as a broad portfolio of IT services make S&T a sought-after partner for customers in a wide variety of industries.

>> Visit 59 other partners at

Latest Blogs

»In the news section: Marinomed, VIG, stock market outlook, SBO, UBM, Verbund (Ch …

»Investment boom wobbles, Spotify tip (Christian Drastil)

»Stock market history November 30th: Verbund with MSCI madness effect (in the positive s …

»Austria custody account at Addiko reaches double digits (De …

»Albert Schmidbauer rings the opening bell for Monday chooseoptimism

»The couple accumulated 6.2 million euros in their share portfolio with buy and hold (Ti …

»AmerisourceBergen (ABC): Pharmaceutical distributor could with corona vaccine …

»ATX-Trends: Verbund, RBI, UBM, VIG, Marinomed, FACC …

»Between Nordic TV sports (Christian Drastil via Runplugged Runkit)

»HM as a chat with Marion Pelzel, dedicated to the association (Christian Dr …

Source link


Please enter your comment!
Please enter your name here